Table 1. Characteristics of the Study Population.
Variable | No. (%) |
---|---|
Age, median (IQR), y | 59 (50-69) |
Year of breast cancer diagnosis | |
July-December 2006 | 21 841 (5.0) |
2007-2009 | 138 482 (31.5) |
2010-2012 | 139 592 (31.7) |
2013-2015 | 139 789 (31.8) |
Affiliation with complementary universal health insurancea | 19 376 (7.2) |
Comorbidities | |
Measurable history of smoking | 24 923 (5.7) |
Alcohol use disorder | 7113 (1.6) |
Obesity | 56 174 (12.8) |
Medical contraceptionb | |
IUD | 24 260 (22.7) |
Birth control pill (reimbursed by health insurance) | 12 153 (11.4) |
Birth control implant | 1676 (1.6) |
Hormone replacement therapyc | 47 674 (12.7) |
Breast cancer type | |
Invasive | 409 523 (93.1) |
In situ | 30 181 (6.9) |
Breast cancer diagnosisd | |
Mammography | 89 427 (95.5) |
Biopsy | 87 182 (93.1) |
Ultrasonography | 87 075 (93.0) |
MRI | 29 506 (31.5) |
PET scan | 1332 (1.4) |
Breast cancer treatmente | |
Surgical procedure | 365 318 (83.1) |
Radiation therapy | 334 678 (76.1) |
Chemotherapy | 186 142 (42.3) |
Hormone therapy | 291 007 (66.2) |
Anti–HER2 | 41 363 (9.4) |
Growth factors (antianemic/hematopoietic) | 118 692 (27.0) |
Abbreviations: IQR, interquartile range; IUD, intrauterine device; MRI, magnetic resonance imaging; PET, positron emission tomography.
Free access to health care for people with an annual income less than 50% of the poverty threshold and younger than 65 years (n = 169 031).
For patients younger than 50 years (n = 107 004).
For patients aged 45 years or older (n = 374 208).
For patients included in 2014-2015 (n = 93 615).
For any corresponding reimbursement registered within 1 year of cohort entry.